Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine

Acta Haematol. 2001;105(2):106-8. doi: 10.1159/000046545.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Disease-Free Survival
  • Drug Administration Schedule
  • Humans
  • Immunoblastic Lymphadenopathy / classification
  • Immunoblastic Lymphadenopathy / diagnosis
  • Immunoblastic Lymphadenopathy / drug therapy*
  • Lymphoma, T-Cell / classification
  • Lymphoma, T-Cell / diagnosis
  • Lymphoma, T-Cell / drug therapy
  • Male
  • Middle Aged
  • Treatment Outcome
  • Vidarabine / administration & dosage*
  • Vidarabine / analogs & derivatives*

Substances

  • Vidarabine
  • fludarabine